Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the Press Release on December 08, 2021 titled ‘SPARC Licenses Development and Commercialization Rights of PDP-716 and SDN-037 to Visiox Pharma’.
The above information is a part of company’s filings submitted to BSE.